Behavioural screening in mutagenised mice - In search for novel animal models of psychiatric disorders

European Journal of Pharmacology

Volumn 480, Issue 1-3, 2003, Pages 219-228

  Ohl, Frauke ^a   Keck, Martin E ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Animal model; Behaviour; Candidate gene; ENU (ethyl nitrosourea); High throughput screen; Mutagenesis; Psychiatric disorder

Indexed keywords

ETHYLNITROSOUREA;

ANIMAL BEHAVIOR; CONFERENCE PAPER; DISEASE MODEL; EXPERIMENTAL MODEL; GENETIC PREDISPOSITION; GENETIC SCREENING; MENTAL DISEASE; MOUSE MUTANT; MUTAGENESIS; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0242667614     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.08.108     Document Type: Conference Paper

References (90)

1. Andreasen N.C. Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science. 275:1997;1586-1593.
2. Antoch M.P., Song E.J., Chang A.M., Vitaterna M.H., Zhao Y., Wilsbacher L.D., Sangoram A.M., King D.P., Pinto L.H., Takahashi J.S. Functional identification of the mouse circadian Clock gene by transgenic BAC rescue. Cell. 89:1997;655-667.
3. Balling R. ENU mutagenesis: analyzing gene function in mice. Ann. Rev. Genom. Hum. Genet. 2:2001;463-492.
4. Barnett S.A. The Rat: A Study in Behavior. 1963;. Metheun, London.
5. Beckers J., Hrabé de Angelis M. Large-scale mutational analysis for the annotation of the mouse genome. Curr. Opin. Chem. Biol. 6:2002;17-23.
6. Belzung C. Measuring rodent exploratory behavior. Crusio W.E., Gerlai R.T. Handbook of Molecular Genetic Techniques for Brain and Behavior Research (Techniques in the Behavioral and Neural Sciences). 1999;738-749 Elsevier, Amsterdam.
7. Belzung C., Berton F. Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of anxiety. Behav. Pharmacol. 8:1997;541-548.
8. Belzung C., Griebel G. Measurement of normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125:2001;141-149.
9. Belzung C., Le Pape G. Comparison of different behavioral test situations used in psychopharmacology for measurements of anxiety. Physiol. Behav. 56:1994;623-628.
10. Bakshi V.P., Kalin N. Animal models and endophenotypes of anxiety and stress disorders. Davis K.L., Charney D., Coyle J.T., Nemeroff C. Neuropsychopharmacology. The Fifth Generation of Progress. 2002;445-456 Lippincott, Williams and Wilkins, Philadelphia.
11. Blanchard R.J., Blanchard D.C. Anti-predator defense behaviors in a visible burrow system. J. Comp. Psychol. 103:1989;70-82.
12. Blanchard R.J., Yudko E.B., Rodgers R.J., Blanchard D.C. Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety. Behav. Brain Res. 58:1993;155-165.
13. Blanchard R.J., Griebel G., Henrie J.A., Blanchard D.C. Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries. Neurosci. Biobehav. Rev. 21:1997;783-789.
14. Blanchard D.C., Griebel G., Blanchard R.J. Mouse defensive behavior: pharmacological and behavioral assays for anxiety and panic. Neurosci. Biobehav. Rev. 25:2001;205-218.
15. Blanchard D.C., Hynd A.L., Minke K.A., Minemoto T., Blanchard R.J. Human defense behaviors to threat scenarios show parallels to fear- and anxiety-related defense patterns of non-human mammals. Neurosci. Biobehav. Rev. 25:2001;761-770.
16. Brown S.D.M. Mouse models of genetic disease: new approaches, new paradigms. J. Inherit. Metab. Dis. 21:1998;532-539.
17. Brown S.D.M., Balling R. Systematic approaches to mouse mutagenesis. Curr. Opin. Genet. Dev. 11:2001;268-273.
18. Brown S.D.M., Hardisty R.E. Mutagenesis strategies for identifying novel loci associated with disease phenotypes. Semin. Cell Dev. Biol. 14:2003;19-24.
19. Brunner H.G., Nelen M., Breakenfield X.O., Ropers H.H., Vanoost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase. Science. 262:1993;560-578.
20. Carlson C.S., Newman T.L., Nickerson D.A. SNPing in the human genome. Curr. Opin. Chem. Biol. 5:2001;78-85.
21. Caterini F., Della S.S., Spinnler C. Object recognition and object orientation in Alzheimer's disease. Neuropsychology. 16:2002;146-155.
22. Clement Y., Proeschel M.F., Bondoux D., Girard F., Launay J.M., Chapouthier G. Genetic factors regulate processes related to anxiety in mice. Brain Res. 752:1997;127-135.
23. Crabbe J.C. Genetic differences in locomotor activity in mice. Pharmacol. Biochem. Behav. 25:1986;289-292.
24. Crawley J.N. Evaluating anxiety in rodents. Crusio W.E., Gerlai R.T. Handbook of Molecular Genetic Techniques for Brain and Behavior Research (Techniques in the Behavioral and Neural Sciences). 1999;667-673 Elsevier, Amsterdam.
25. Crawley L.N., Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 13:1980;167-170.
26. Crawley J.N., Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotype of transgenic and knockout mice. Horm. Behav. 31:1997;197-211.
27. Crawley J.N., Belknap J.K., Collins A., Crabbe J.C., Frankel W., Henderson N., Hitzemann R.J., Maxson S.C., Miner L.J., Silva A.J., Wehner J.M., Wynshaw-Boris A., Paylor R. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology. 132:1997;107-124.
28. Cruz A.P.M., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-176.
29. Dalvi A., Lucki I. Murine models of depression. Psychopharmacology. 147:1999;14-16.
30. De Pablo J.M., Parra A., Segovia S., Guillarmón A. Learned immobility explains the behavior of rats in the forced swimming test. Physiol. Behav. 46:1989;229-237.
31. Doninger G.M., Silipo G., Rabinowicz E.F., Snodgrass J.G., Javitt D.C. Impaired sensory processing as a basis for object-recognition deficits in schizophrenia. Am. J. Psychiatry. 158:2001;1818-1826.
32. Escorihuela R.M., Fernandez-Teruel A., Gil L., Aguilar R., Tobena A., Driscoll P. Inbred Roman high- and low-avoidance rats: differences in anxiety, novelty-seeking, and shuttlebox behavior. Physiol. Behav. 67:1999;19-26.
33. Ferre P., Fernandez-Teruel A., Escorihuela R.M., Driscoll P., Gercia E., Zapata A., Tabena A. Struggling and flumazenil effects in the swimming test are related to the level of anxiety in mice. Neuropsychobiology. 29:1994;23-27.
34. File S.E., Wardill A.G. Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia (Berlin, West). 44:1975;53-59.
35. Flint J., Corley R., De Fries J.C., Fulker D.W., Gray J.A., Miller S., Collins A.C. A simple genetic basis for a complex psychological trait in laboratory mice. Science. 269:1995;1432-1435.
36. Freedman R., Adler L.E., Leonard S. Alternative phenotypes for the complex genetics of schizophrenia. Biol. Psychiatry. 45:1999;551-558.
37. Geyer M.A., Markou A. The role of preclinical models in the development of psychotropic drugs. Davis K.L., Charney D., Coyle J.T., Nemeroff C. Neuropsychopharmacology. The Fifth Generation of Progress. 2002;445-456 Lippincott, Williams and Wilkins, Philadelphia.
38. Golani I., Kafkafi N., Drai D. Phenotyping stereotypic behavior: collective variables, range of variation and predictability. Appl. Anim. Behav. Sci. 65:1999;191-220.
39. Graeff F.G. On serotonin and experimental anxiety. Psychopharmacology. 163:2002;467-476.
40. Griebel G., Moreau J.-L., Jenck F., Martin J.R., Misslin R. Some critical determinants of the behavior of rats in the elevated plus-maze. Behav. Processes. 29:1993;37-48.
41. Hall C.S. Emotional behavior in the rat: III. The relationship between emotionality and ambulatory activity. J. Comp. Physiol. Psychol. 22:1936;345-352.
42. Handley S.L., Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze exploration model for "fear-motivated" behavior. Naunyn-Schmiedeberg's Arch. Pharmacol. 327:1984;1-5.
43. Heils A., Teufel A., Petri S.et al. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66:1996;2621-2624.
44. Hodges H. Maze procedures: the radial-arm and water maze compared. Cogn. Brain Res. 3:1996;167-181.
45. Hogg S. A review of the validity and variability of the elevated plus maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54:1996;21-30.
46. Holsboer F. Transgenic mouse models: new tools for psychiatric research. Neuroscientist. 3:1997;328-336.
47. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. 33:1999;181-214.
48. Hrabé de Angelis M., Flaswinkel H., Fuchs H., Rathkolb B., Soewarto D., Marschall S., Heffner S., Pargent W., Wuensch K., Jung M., Reis A., Richter T., Alessandrini F., Jakob T., Fuchs E., Kolb H., Kremmer E., Schaeble K., Rollinski B., Roscher A., Peters C., Meitinger T., Strom T., Steckler T., Holsboer F., Klopstock T., Gekeler T., Schindewolf C., Jung T., Avraham K., Behrendt H., Ring J., Zimmer A., Schughart K., Pfeffer K., Wolf E., Balling R. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet. 25:2000;444-447.
49. Hunter A.J., Nolan P.M., Brown S.D.M. Towards new models of disease and physiology in the neuroscience: the role of induced and naturally occurring mutations. Hum. Mol. Genet. 9:2000;893-900.
50. Hyman S.E. Introduction to the complex genetics of mental disorders. Biol. Psychiatry. 45:1999;518-521.
51. Justice M.J., Carpenter D.A., Favor J., Neuhäuser-Klaus A., Hrabe de Angelis M. Effects of ENU dosage on mouse strains. Mamm. Genome. 11:2000;484-488.
52. Keck M.E., Welt T., Post A., Müller M.B., Toschi N., Wigger A., Landgraf R., Holsboer F., Engelmann M. Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology. 24:2001;337-349.
53. Keck M.E., Wigger A., Welt T., Müller M.B., Gesing A., Reul J.M.H.M., Holsboer F., Landgraf R., Neumann I.D. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology. 26:2002;94-105.
54. Keck M.E., Welt T., Müller M.B., Uhr M., Ohl F., Wigger A., Toschi N., Holsboer F., Landgraf R. Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of the antidepressant paroxetine in a psychopathological rat model. Neuropsychopharmacology. 28:2003;235-243.
55. Kendler K.S. Psychiatric genetics: an intellectual journey. Clin. Neurosci. Res. 2:2002;110-119.
56. Kelley A.E. Locomotor activity and exploration. Sahgal A. Behavioural Neuroscience: A Practical Approach. 1993;1-21 Oxford Univ. Press, Oxford.
57. King D.P., Zhao Y., Sangoram A.M., Wilsbacher L.D., Tanaka M.et al. Positional cloning of the mouse circadian Clock gene. Cell. 89:1997;641-653.
58. Kirchheiner J., Brosen K., Dahl M.L.et al. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages. Acta Psychiatr. Scand. 104:2001;173-192.
59. Lee W.R., Arbour P., Fossett N.G., Kilroy G., Mahmoud J., McDaniel M.L., Tucker A. Sequence-analysis of x-ray and ENU induced mutations at the ADH locus in Drosphilia-Melanogaster. Genetics. 122:1989;S38-S38.
60. Lister R.G. Ethologically based animal models of anxiety disorders. Pharmacol. Ther. 46:1990;321-340.
61. Lyon M.F., Rastan S., Brown S.D.M. Genetic Variants and Strains of the Laboratory Mouse. 3rd ed. 1996;Oxford Univ. Press, Oxford.
62. Montgomery K.C. The relation between fear induced by novel stimulation and exploratory behavior. J. Comp. Physiol. Psychol. 48:1958;254-260.
63. Montkowski A., Barden N., Wotjak C., Stec I., Ganster J., Meaney M., Engelmann M., Reul J.M.H.M., Landgraf R., Holsboer F. Long-term antidepressant treatment reduces behavioral deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol. 7:1995;841-845.
64. Müller M.B., Keck M.E. Genetically engineered mice for studies of stress-related clinical conditions. J. Psychiatr. Res. 36:2002;53-76.
65. Nolan P.M., Peters J., Strivens M., Rogers D., Hagan J., Spurr N., Gray I.C., Vizor L., Brooker D., Whitehill E., Washbourne R., Hough T., Greenaway S., Hewitt M., Liu X., McCormack S., Pickford K., Selley R., Wells C., Tymowska-Lalanne Z., Roby P., Glenister P., Thornton C., Thaung C., Stevenson J.A., Arkell R., Mburu P., Hardisty R., Kiernan A., Erven A., Steel K.P., Voegeling S., Guenet J.L., Nickols C., Sadri R., Nasse M., Isaacs A., Davies K., Browne M., Fisher E.M., Martin J., Rastan S., Brown S.D., Hunter J. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat. Genet. 25:2000;440-443.
66. Ohl F., Holsboer F., Landgraf R. The modified hole board as differential screen for behavior in rodents. Behav. Res. Meth. Instrum. Comput. 33:2001;392-397.
67. Ohl F., Sillaber I., Binder E., Keck M.E., Holsboer F. Differential analysis of basal behavior and diazepam-induced alterations in C57BL/6 and BALB/c mice using the modified hole board. J. Psychiatr. Res. 35:2001;147-154.
68. Ohl F., Toschi N., Wigger A., Henniger M.S.H., Landgraf R. Dimensions of emotionality in an animal model of inborn hyperanxiety. Behav. Neurosci. 115:2001;429-436.
69. Ohl F., Roedel A., Storch C., Holsboer F., Landgraf R. Cognitive performance in rats differing in their inborn anxiety. Behav. Neurosci. 116:2002;464-471.
70. Ohl F., Roedel A., Binder E., Holsboer F. Impact of high and low anxiety on cognitive performance in a modified hole board test in inbred mice strains C57BL/6 and DBA/2. Eur. J. Neurosci. 17:2003;128-136.
71. Owen M.J., Cardno A.G., O'Donovan M.C. Psychiatric genetics: back to the future. Mol. Psychiatry. 5:2000;22-31.
72. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
73. Picciotto M.R. Knock-out mouse models used to study neurobiological systems. Crit. Rev. Neurobiol. 13:1999;103-149.
74. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229:1977;327-336.
75. Rawlins, J.N.P., Deacon, R.M.J., 1993. Further development in maze procedures. In: Saghal, A. (Ed.), Behavioral Neuroscience: A Practical Approach, vol. 1. IRL Press at Oxford Univ. Press, Oxford, pp. 95-106.
76. Rodgers R.J., Johnson N.J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52:1995;297-303.
77. Rodgers R.J., Cole J.C., Cobain M.R., Daly P., Doran P.J., Eells J.R., Wallis P. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus maze: profile comparison with 8-OH-DPAT, TFMPP and mCPP. Behav. Pharmacol. 3:1992;621-624.
78. Rodgers R.J., Cao B.J., Dalvi A., Holmes A. Animal models of anxiety: an ethological perspective. Braz. J. Med. Biol. Res. 30:1997;289-304.
79. Rogers D.C., Jones D.N.C., Nelson P.R., Jones C.M., Quilter C.A., Robinson T.L., Hagan J.J. Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav. Brain Res. 105:1999;207-217.
80. Rossant J., McKerlie C. Mouse-phenogenomics for modelling human disease. Trends Mol. Med. 7:2001;502-507.
81. Sayah D.M., Khan A.H., Gasperoni T.L., Smith D.J. A genetic screen for novel behavioral mutations in mice. Mol. Psychiatry. 5:2000;369-377.
82. Seong E., Seasholtz A.F., Burmeister M. Mouse models for psychiatric disorders. Trends Genet. 18:2002;643-650.
83. Sheldon M.H. Exploratory behaviour: the inadequacy of activity measures. Psychol. Sci. 11:1968;38.
84. Spruijt B.M., van den Bos R., Pijlman F.T.A. A concept of welfare based on reward evaluating mechanisms in the brain: anticipatory behaviour as reward systems. Appl. Anim. Behav. Sci. 72:2001;145-171.
85. Tabor H.K., Risch N.J., Myers R.M. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat. Rev. Genet. 3:2002;391-397.
86. Tarantino L.M., Gould T.J., Druhan J.P., Bucan M. Behavior and mutagenesis screens: the importance of baseline analysis of inbred strains. Mamm. Genome. 11:2000;555-564.
87. Treit D., Fundytus M. Thigmotaxis as a test of anxiolytic activity in rats. Pharmacol. Biochem. Behav. 31:1989;959-962.
88. Vitaterna M.H., King D.P., Chang A.M., Kornhauser J.M., Lowrey P.L., McDonald J.D., Dove W.F., Pinto L.H., Turek F.W., Takahashi J.S. Mutagenesis and mapping of a mouse gene, clock, essential for circadian behavior. Science. 264:1994;719-725.
89. Von Frijtag J.C., Reijmers L.G., Van der Harst J.E., Leus I.E., Van den Bos R., Spruijt B.M. Defeat followed by individual housing results in long-term impaired reward- and cognition-related behaviours in rats. Behav. Brain Res. 117:2000;137-146.
90. Wilson J.H. A conspecific attenuates prolactin responses to open-field exposure in rats. Horm. Behav. 38:2000;39-43.